American Reprographics Company (ARC) 3.95 $ARC Project

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
American Reprographics Company (ARC) 3.95 $ARC

Project Information Management Services by ARC Document Solutions Improves Active Construction Project Execution and Closeout
PR Newswire - Thu Jun 16, 7:00AM CDT
ARC Document Solutions, Inc. (NYSE: ARC), a leading document solutions provider to design, engineering, construction, and facilities management professionals, today introduced its Project Information Management (PIM) services, a major addition to its Construction Document and Information Management solutions. Designed for active construction projects with thousands of documents, PIM offers quick and easy access to building plans and other information from a centralized, graphic dashboard. Once a project is complete, the dashboard and associated documents can then be turned over to the project owners to facilitate building operations.
ARC: 3.95 (-0.10)

Architecture Firm Doubles Productivity With BIM Services From ARC Document Solutions
PR Newswire - Thu May 19, 7:00AM CDT
Architects are hired for their expertise and experience, but it's their vision of a project that typically drives their success. That's why renowned Hawaiian design firm Benjamin Woo Architects (BWA) was so careful about choosing their partner for building information modeling (BIM) services on their part of a $1 billion Park Lane Ala Moana design project - they needed someone who could not only help articulate their vision but also expand their horizons.
ARC: 3.95 (-0.10)

ARC Document Solutions Reports Results for First Quarter 2016
Marketwired - Tue May 03, 3:05PM CDT
ARC Document Solutions, Inc. (NYSE: ARC), a leading document solutions provider to design, engineering, construction, and facilities management professionals, today reported its financial results for the first quarter ended March 31, 2016.
ARC: 3.95 (-0.10)

ARC Document Solutions Introduces Facilities Information Management at the AIIM Conference 2016
PR Newswire - Tue Apr 26, 7:00AM CDT
ARC Document Solutions, Inc. (NYSE: ARC), the nation's leading document solutions provider for architects, engineers and the construction industry in the areas of design, building and facilities, and plant operations management, will be demonstrating its Facilities Information Management (FIM) solution at Booth #40 at the annual conference of the Association for Information and Image Management (AIIM) being held in New Orleans from April 26 through April 28.
ARC: 3.95 (-0.10)

ARC Document Solutions Announces 2016 First Quarter Conference Call
Marketwired - Mon Apr 11, 12:37PM CDT
ARC Document Solutions, Inc. (NYSE: ARC), the nation's leading document solutions provider for the architecture, engineering, and construction (AEC) industry, today announced that it will hold a conference call with investors and analysts on Tuesday, May 3, 2016, at 2 P.M. Pacific Time (5 P.M. Eastern Time) to discuss results for the company's 2016 first quarter.
ARC: 3.95 (-0.10)

Gartner Positions ARC Document Solutions in 2015 Magic Quadrant for Managed Print and Content Services
Marketwired - Tue Feb 09, 1:48PM CST
ARC Document Solutions Inc. (NYSE: ARC), the nation's leading document solutions provider for the architecture, engineering, and construction (AEC) industry, today announced it has been positioned as a niche player in the December 21, 2015, Magic Quadrant for Managed Print and Content Services, published by Gartner Inc. (NYSE: IT). ARC is the only company listed in the report with its principle market emphasis on the architectural, engineering and construction industry. Depending on the needs of its clients, ARC uses a variety of MFPs, as well as conventional and wide-format printers from different manufacturers to fulfill its offering.
ARC: 3.95 (-0.10), IT: 96.09 (-3.73)

ARC Document Solutions Survey Identifies Current Construction Technology Trends
PR Newswire - Thu Jan 28, 7:03AM CST
ARC Document Solutions, Inc. (NYSE: ARC) ("ARC" , a leading document and information management solutions provider for the architecture, engineering and construction (AEC) industry, today announced the results of an industry survey that reveal participants' views on emerging technologies, including Big Data, drones and the so-called "Internet of Things" (IoT). The top prediction, named by 65.3 percent of respondents, is that virtual reality applications will be used much more in the future to experience a building's design before it is built.
ARC: 3.95 (-0.10)

ARC Document Solutions Announces 2015 Fourth Quarter and Fiscal Year-End Conference Call
Marketwired - Mon Jan 25, 5:31PM CST
ARC Document Solutions, Inc. (NYSE: ARC), the nation's leading document solutions provider for the architecture, engineering, and construction (AEC) industry, today announced that it will hold a conference call with investors and analysts on Tuesday, February 23, 2016, at 2 P.M. Pacific Time (5 P.M. Eastern Time) to discuss results for the company's 2015 fourth quarter and fiscal year-end.
ARC: 3.95 (-0.10)

CEO of ARC Document Solutions Offers 2015 Year-End Perspective
Marketwired - Thu Dec 17, 11:27PM CST
ARC Document Solutions, Inc. (NYSE: ARC), the nation's leading document solutions provider for the construction industry, today released an open letter from K. "Suri" Suriyakumar, the Company's Chairman, President and CEO, offering a forward-looking perspective on the company's transformation. The letter is available on the Company's investor relations website at ir.e-arc.com.
ARC: 3.95 (-0.10)

Should You Get Rid of ARC Document Solutions (ARC) Now?
Zacks Equity Research - Zacks Investment Research - Mon Nov 23, 7:39AM CST
ARC Document Solutions has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off
ARC: 3.95 (-0.10), CMPR: 93.17 (-4.82)

Beyond the Chart, What Price Data Reveals - Research on Endochoice Holdings, Catalyst Pharmaceuticals, Aquinox Pharmaceuticals and ARC Document Solutions
ACCESSWIRE - Thu Nov 19, 7:45AM CST
NEW YORK, NY / ACCESSWIRE / November 19, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Endochoice Holdings Inc. (NYSE: GI), Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX), Aquinox Pharmaceuticals Inc. (NASDAQ: AQXP) and ARC Document Solutions Inc. (NYSE: ARC). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ARC: 3.95 (-0.10), AQXP: 6.50 (-0.22), CPRX: 0.79 (-0.09), GI: 4.82 (-0.05)

ARC Document Solutions Reports Results for Third Quarter 2015
Marketwired - Wed Nov 04, 3:05PM CST
ARC Document Solutions, Inc. (NYSE: ARC), the nation's leading document solutions provider for the architecture, engineering, and construction (AEC) industry, today reported its financial results for the third quarter ended September 30, 2015.
ARC: 3.95 (-0.10)

BUYINS.NET: ARC SqueezeTrigger Price is $6.39. There is $5,978,304 That Short Sellers Still Need To Cover.
M2 - Thu Oct 29, 12:03PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring American Reprographics Co (NYSE:ARC) in real time and just received an alert that ARC is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 931200 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $6.39. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
ARC: 3.95 (-0.10), ARP: 0.33 (unch)

BUYINS.NET: ARC SqueezeTrigger Price is $6.39. There is $6,197,100 That Short Sellers Still Need To Cover.
M2 - Tue Oct 20, 10:15AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring American Reprographics Co (NYSE:ARC) in real time and just received an alert that ARC is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 953400 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $6.39. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
ARC: 3.95 (-0.10), ARP: 0.33 (unch)

ARC Document Solutions Introduces Next Generation of Document and Information Distribution Tools for Construction Communication
Marketwired - Tue Oct 13, 7:02AM CDT
ARC Document Solutions, Inc. (NYSE: ARC) ("ARC" , a leading document solutions provider for the construction industry, today announced the introduction of SKYSITE(R) 2.0, the next generation of its cloud-based application for construction communication. The latest version of SKYSITE adds new features such as Request-for-Information (RFI) administration, photo management and punch lists to its industry-leading capabilities in managing and distributing construction documents and information.
ARC: 3.95 (-0.10)

ARC Document Solutions Announces 2015 Third Quarter Results Conference Call
Marketwired - Wed Oct 07, 6:47PM CDT
ARC Document Solutions, Inc. (NYSE: ARC), the nation's leading document solutions provider for the architecture, engineering, and construction (AEC) industry, today announced that it will hold a conference call with investors and analysts on Wednesday, November 4, 2015, at 2 P.M. Pacific Time (5 P.M. Eastern Time) to discuss results for the company's third quarter of 2015.
ARC: 3.95 (-0.10)

Commit To Purchase ARC Document Solutions At $5, Earn 11.3% Annualized Using Options
StockOptionsChannel.com - Wed Oct 07, 10:41AM CDT
Investors considering a purchase of ARC Document Solutions, Inc. shares, but tentative about paying the going market price of $5.94/share, might benefit from considering selling puts among the alternative strategies at their disposal.
ARC: 3.95 (-0.10)

BUYINS.NET: ARC SqueezeTrigger Price is $6.40. There is $5,009,688 That Short Sellers Still Need To Cover.
M2 - Tue Sep 15, 11:53AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring American Reprographics Co (NYSE:ARC) in real time and just received an alert that ARC is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 773100 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $6.40. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
ARC: 3.95 (-0.10), ARP: 0.33 (unch)

ARC Document Solutions to Present at the Midwest Ideas Investor Conference on August 27th in Chicago
Marketwired - Tue Aug 18, 4:41PM CDT
ARC Document Solutions, Inc. (NYSE: ARC), the nation's leading document solutions provider for the architecture, engineering, and construction (AEC) industry, today announced that ARC management will present at the Midwest IDEAS Investor Conference on Thursday, August 27, 2015, at the Hard Rock Hotel in Chicago, Illinois. ARC's presentation is scheduled to begin at 10:40am Central Time. The presentation will be webcast live and may be accessed at the conference website at www.IDEASConferences.com.
ARC: 3.95 (-0.10)

ARC Document Solutions Reports Results for Second Quarter 2015
Marketwired - Tue Aug 04, 3:05PM CDT
ARC Document Solutions, Inc. (NYSE: ARC), the nation's leading document solutions provider for the architecture, engineering, and construction (AEC) industry, today reported its financial results for the second quarter ended June 30, 2015.
ARC: 3.95 (-0.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading